Neuronascent's unique drug discovery platform is being used to identify active compounds that promote increased numbers of mature neurons from neuronal progenitor cells in a cell culture system. These compounds will be developed into small-molecule therapeutics for patients with:

• Alzheimer's disease (AD)
• Depression
• Stroke